Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ-Reference-Cited by-同舟云学术

Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ

Published:2013-03-24 Issue:5 Volume:14 Page:461-469
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Do-Umehara Hanh Chi,Chen Cong,Urich Daniela,Zhou Liang,Qiu Ju,Jang Samuel,Zander Alia,Baker Margaret A,Eilers Martin,Sporn Peter H S,Ridge Karen M,Sznajder Jacob I,Budinger G R Scott,Mutlu Gökhan M,Lin Anning,Liu Jing

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.2566.pdf

Reference48 articles.

1. Sun, S.C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8, 501–511 (2008).

2. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).

3. Aderem, A. & Ulevitch, R.J. Toll-like receptors in the induction of the innate immune response. Nature 406, 782–787 (2000).

4. Hsu, H., Shu, H.B., Pan, M.G. & Goeddel, D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299–308 (1996).

5. Karin, M. & Lin, A. NF-κB at the crossroads of life and death. Nat. Immunol. 3, 221–227 (2002).

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Miz1 represses type I interferon production and limits viral clearance during influenza A virus infection;Science Signaling;2024-04-09

2. Network Pharmacology Analysis of the Therapeutic Potential of Colchicine in Acute Lung Injury;International Journal of Clinical Practice;2024-02-06

3. Azithromycin regulates bacterial virulence and immune response in a murine model of ceftazidime‐treated Pseudomonas aeruginosa acute pneumonia;Microbiology and Immunology;2023-12-10

4. ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification;Journal of Biomedical Science;2023-08-22

5. Tumor-derived microparticles-based nanomaterial as platform for delivery of tumor antigens to enhance immunogenicity;Chemical Engineering Journal;2023-05